BioCentury
ARTICLE | Company News

Receptagen deal

August 29, 1994 7:00 AM UTC

RCG (Vancouver) and the Institute for Biological Sciences of the National Research Council in Ottawa agreed to develop drugs to regulate apoptosis. The parties have been working together to develop drugs that induce apoptosis based on depletion of vitamin B12 in cancer cells. ...